Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid derived suppressor cells in vitro and in vivo

Journal of Leukocyte Biology

Volumn 91, Issue 5, 2012, Pages 701-709

  Rosborough, Brian R ^a   Castellaneta, Antonino ^a   Natarajan, Sudha ^a   Thomson, Angus W ^a   Turnquist, Heth R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cell differentiation; Cytokines; Hematopoiesis; Tolerance suppression anergy

Indexed keywords

ANTIINFLAMMATORY AGENT; CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 4;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL POPULATION; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MYELOID CELLS;

MURINAE; MUS;

EID: 84860902300     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311119     Document Type: Article

References (40)

1. Struhl, K (1998) Histone acetylation and transcriptional regulatory mechanisms. GenesDev. 12, 599-606.
2. Brogdon, J. L., Xu, Y., Szabo, S. J., An, S., Buxton, F., Cohen, D., Huang, Q. (2007) Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 109, 1123-1130.
3. Choudhary, C, Kumar, C, Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C, Olsen, J. V., Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
4. Marks, P. A., Richon, V. M., Breslow, R., Rifkind, R A. (2001) Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol 13, 477-483.
5. Blanchard, F., Chipoy, C. (2005) Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov. Today 10, 197-204.
6. Leng, C, Gries, M., Ziegler, J., Lokshin, A., Mascagni, P., Lentzsch, S., Mapara, M. Y. (2006) Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. Exp. Hematol. 34, 776-787.
7. Mishra, N., Reilly, C. M., Brown, D. R, Ruiz, P., Gilkeson, G. S. (2003) Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111, 539-552.
8. Glauben, R, Batra, A., Fedke, I., Zeitz, M., Lehr, H. A., Leoni, F., Mascagni, P., Fantuzzi, G., Dinarello, C. A., Siegmund, B. (2006) Histone hy-peracetylation is associated with amelioration of experimental colitis in mice. J. Immunol. 176, 5015-5022.
9. Nencioni, A., Beck, J., Werth, D., Grunebach, F., Patrone, F., Ballestrero, A, Brossart, P. (2007) Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin. Cancer Res. 13, 3933-3941.
10. Reddy, P., Sun, Y, Toubai, T., Duran-Struuck, R, Clouthier, S. G., Weisiger, E., Maeda, Y, Tawara, I., Krijanovski, O., Gatza, E., Liu, C, Malter, C, Mascagni, P., Dinarello, C. A., Ferrara, J. L. M. (2008) Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J. Clin. Invest. 118, 2562-2573.
11. Sun, Y, Chin, Y E., Weisiger, E., Malter, C, Tawara, I., Toubai, T., Gatza, E., Mascagni, P., Dinarello, C. A., Reddy, P. (2009) Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J. Immunol. 182, 5899-5903.
12. Banchereau, J., Steinman, R M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
13. Steinman, R M., Hawiger, D., Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
14. Morelli, A. E., Thomson, A. W. (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610-621.
15. Sebastian, C, Serra, M., Yeramian, A., Serrat, N., Lloberas, J., Celada, A. (2008) Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180, 5898-5906.
16. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
17. Highfill, S. L., Rodriguez, P. C, Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R, Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J. S., Munn, D. H., Tolar, J., Ochoa, A. C, Blazar, B. R (2010) Bone marrow myeloid-derived suppressor cells (MDSC) inhibit graft-versus-host (GVHD) disease via an arginase-1 dependent mechanism that is upregulated by IL-13. Blood 116, 5738-5747.
18. Serafini, P., Carbley, R, Noonan, K A., Tan, G., Bronte, V., Borrello, I. (2004) High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64, 6337-6343.
19. Garcia, M. R, Ledgerwood, L., Yang, Y, Xu, J., Lal, G., Burrell, B., Ma, G, Hashimoto, D., Li, Y, Boros, P., Grisotto, M., Rooijen, N. V., Mate-sanz, R, Tacke, F., Ginhoux, F., Ding, Y, Chen, S-H., Randolph, G., Merad, M., Bromberg, J. S., Ochando, J. C. (2010) Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Invest. 120, 2486-2496.
20. + T cell stimulatory and differentiation capacity of myeloid DC following exposure to LPS. Blood 115, 4758-4769.
21. Kodumudi, K N., Woan, K, Gilvary, D. L., Sahakian, E., Wei, S., Djeu, J.Y. (2010) A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin. Cancer Res. 16, 4583-4594.
22. Hackstein, H., Taner, T., Zahorchak, A. F., Morelli, A. E., Logar, A. J., Gessner, A., Thomson, A. W. (2003) Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101, 4457-4463.
23. Liu, K, Victora, G. D., Schwickert, T. A., Guermonprez, P., Meredith, M. M., Yao, K, Chu, F-F., Randolph, G. J., Rudensky, A. Y, Nussenzweig, M. (2009) In vivo analysis of dendritic cell development and homeostasis. Science 324, 392-397.
24. Greifenberg, V., Ribechini, E., Rossner, S., Lutz, M. B. (2009) Myeloid-derived suppressor cell activation by combined LPS and IFN-7 treatment impairs DC development. Eur. J. Immunol. 39, 2865-2876.
25. He, Y, Pimenov, A. A., Nayak, J. V., Plowey, J., Falo, L. D., Huang, L. (2000) Intravenous injection of naked DNA encoding secreted Flt3 li-gand dramatically increases the number of dendritic cells and natural killer cells in vivo. Hum. Gene Ther. 11, 547-554.
26. Xu, Y, Zhan, Y, Lew, A. M., Naik, S. H., Kershaw, M. H. (2007) Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 179, 7577-7584.
27. Rossner, S., Voigtlander, C, Wiethe, C, Hanig, J., Seifarth, C, Lutz, M. B. (2005) Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35, 3533-3544.
28. De Wilde, V., Van Rompaey, N., Hill, M., Lebrun, J. F., Lemâitre, P., Lhomme, F., Kubjak, C, Vokaer, B., Oldenhove, G., Charbonnier, L. M., Cuturi, M. C, Goldman, M., Le Moine, A. (2009) Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxy-genase-1. Am. J. Transplant. 9, 2034-2047.
29. Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Sauntha-rarajah, Y, Hoffman, R (2004) Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. Blood 103, 4102-4110.
30. Bug, G., Gul, H., Schwarz, K, Pfeifer, H., Kampfmann, M., Zheng, X., Beissert, T., Boehrer, S., Hoelzer, D., Ottmann, O. G., Ruthardt, M. (2005) Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res. 65, 2537-2541.
31. De Felice, L., Tatarelli, C, Mascolo, M. G., Gregorj, C, Agostini, F., Fiorini, R, Gelmetti, V, Pascale, S., Padula, F., Petrucci, M. T., Arcese, W., Nervi, C. (2005) Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res. 65, 1505-1513.
32. Araki, H., Yoshinaga, K, Boccuni, P., Zhao, Y, Hoffman, R, Mahmud, N. (2007) Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 109, 3570-3578.
33. Seet, L-F., Teng, E., Lai, Y-S., Laning, J., Kraus, M., Wnendt, S., Merchav, S., Chan, S. L. (2009) Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions. Eur. J. Haematol. 82, 124-132.
34. Mahlknecht, U., Schonbein, C. (2008) Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells. Haematologica 93, 443-446.
35. Yuan, Z-L., Guan, Y-J., Chatterjee, D., Chin, Y E. (2005) Stat3 dimeriza-tion regulated by reversible acetylation of a single lysine residue. Science 307, 269-273.
36. Menetrier-Caux, C, Montmain, G., Dieu, M. C, Bain, C, Favrot, M. C, Caux, C, Blay, J. Y (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778-4791.
37. Matsuda, T., Nakamura, T., Nakao, K, Arai, T., Katsuki, M., Heike, T., Yokota, T. (1999) STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBOJ. 18, 4261-4269.
38. Zhou, Z., French, D. L., Ma, G., Eisenstein, S., Chen, Y, Divino, C. M., Keller, G., Chen, S-H., Pan, P-Y (2010) Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 28, 620-632.
39. Haile, L. A., von Wasielewski, R, Gamrekelashvili, J., Kruger, C, Bach-mann, O., Westendorf, A. M., Buer, J., Liblau, R, Manns, M. P., Korangy, F., Greten, T. F. (2008) Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135, 871-881.
40. + myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86, 1125-1134.